Belgium vs Latvia: Immunization, Hib3
Belgium
97.0%
in 2024
Latvia
97.0%
in 2024
Belgium rank
29th
Latvia rank
29th
Immunization, Hib3 over time
- Belgium
- Latvia
How they compare
Belgium currently reports 97.0% against 97.0% in Latvia, a difference of 0.0%.
The two have swapped places 9 times across 31 shared years of data; in 1994 it was Belgium ahead.
Belgium ranks 29th and Latvia ranks 29th of 191 countries.
Across the 4 decades both report, Belgium averaged higher in 2 and Latvia in 2.
Head to head by decade
| Decade | Belgium | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.8% | 48.8% | 26.0% | Latvia |
| 2000s | 91.9% | 92.1% | 0.2% | Latvia |
| 2010s | 97.6% | 94.2% | 3.4% | Belgium |
| 2020s | 97.0% | 96.4% | 0.6% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Belgium or Latvia?
- Belgium, at 97.0% against 97.0% in Latvia as of 2024.
- What is the difference in immunization, hib3 between Belgium and Latvia?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Latvia?
- 31 years are reported by both, from 1994 to 2024.
- How do Belgium and Latvia rank globally for immunization, hib3?
- Belgium ranks 29th and Latvia ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.